RECURSION PHARMACEUTICALS, INC. (RXRX)

Latest Insider Confidence Score

2026Q1

50.4
Bullish

Company insider confidence (by quarter)

2021Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Lux Ventures IV, L.P. 10% Owner 13,021,519 Dec 9, 2021
Lux Venture Partners IV, LLC 10% Owner 13,021,519 Dec 9, 2021
Lux Co-Invest Opportunities, L.P. 10% Owner 13,021,519 Dec 9, 2021
Lux Co-Invest Partners, LLC 10% Owner 13,021,519 Dec 9, 2021
Hebert Peter — 13,021,519 Dec 9, 2021

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 3, 2026 Mar 4, 2026 Borgeson Blake Director Sell 20.0 -170,000 -2.64% ✗ $588.2K
Feb 17, 2026 Feb 19, 2026 Hallett David Chief Scientific Officer Sell 46.3 -11,908 -1.07% ✗ $41.6K
Feb 17, 2026 Feb 19, 2026 Gibson Christopher Director Sell 38.8 -67,265 -3.58% ✓ $233.6K
Feb 17, 2026 Feb 19, 2026 Taylor Ben R CFO Sell 42.5 -25,334 -2.08% ✓ $82.9K
Feb 17, 2026 Feb 19, 2026 Khan Najat CEO Sell 48.8 -14,280 -0.62% ✗ $49.8K
Feb 6, 2026 Feb 10, 2026 Khan Najat CEO Sell 91.3 +1,693,528 277.11% ✗ $41.2K
Feb 6, 2026 Feb 10, 2026 Taylor Ben R CFO Sell 91.3 +459,133 60.29% ✗ $45.4K
Feb 6, 2026 Feb 10, 2026 Hallett David Chief Scientific Officer Sell 91.3 +514,918 86.67% ✗ $45.4K
Feb 4, 2026 Feb 6, 2026 Gibson Christopher Director Sell 42.5 -20,018 -2.10% ✓ $201.7K
Feb 3, 2026 Feb 6, 2026 Borgeson Blake Director Sell 37.5 -220,000 -3.31% ✓ $924K
Jan 20, 2026 Jan 22, 2026 Gibson Christopher Director Sell 38.8 -40,000 -4.19% ✓ $178.8K
Jan 9, 2026 Hallett David CSO Neutral 52.5 - 0.00% ✗ -
Jan 6, 2026 Jan 8, 2026 Borgeson Blake Director Sell 37.5 -220,000 -3.20% ✓ $959.2K
Jan 5, 2026 Jan 7, 2026 Gibson Christopher Director Sell 33.8 -60,000 -6.16% ✓ $170K
Jan 2, 2026 Jan 6, 2026 Dar Zavain Director Neutral 82.5 +3,571 2.57% ✗ -
Jan 2, 2026 Jan 6, 2026 Li Dean Y Director Neutral 55.0 +2,381 0.07% ✗ -
Dec 29, 2025 Dec 30, 2025 Taylor Ben R CFO Sell 42.5 -21,383 -2.73% ✓ $89.4K
Dec 22, 2025 Dec 29, 2025 Khan Najat Chief R&D Commercial Officer Sell 20.0 -124,403 -16.91% ✓ $548.6K
Dec 19, 2025 Dec 19, 2025 Gibson Christopher CEO Sell 37.5 -40,000 -4.19% ✓ $180K
Dec 15, 2025 Dec 17, 2025 Taylor Ben R CFO Sell 48.8 -7,057 -0.89% ✗ $30.6K
Dec 4, 2025 Dec 5, 2025 Gibson Christopher CEO Sell 32.5 -60,000 -6.16% ✓ $185.2K
Dec 2, 2025 Dec 4, 2025 Borgeson Blake Director Sell 35.0 -220,000 -3.10% ✓ $961.4K
Nov 25, 2025 Nov 26, 2025 Taylor Ben R CFO Sell 52.5 -2,271 -0.29% ✗ $9.2K
Nov 17, 2025 Nov 19, 2025 Taylor Ben R CFO Sell 46.3 -11,908 -1.48% ✗ $49.3K
Nov 17, 2025 Nov 19, 2025 Khan Najat Chief R&D Commercial Officer Sell 42.5 -17,584 -2.33% ✗ $72.8K
Nov 17, 2025 Nov 19, 2025 Gibson Christopher CEO Sell 35.0 -80,390 -4.21% ✓ $333.6K
Nov 5, 2025 Nov 6, 2025 Khan Najat Chief R&D Commercial Officer Neutral 90.0 +84,925 12.71% ✗ -
Nov 4, 2025 Nov 6, 2025 Gibson Christopher CEO Sell 32.5 -60,000 -5.92% ✓ $208.4K
Oct 23, 2025 Oct 24, 2025 Gibson Christopher CEO Sell 26.3 -100,000 -9.49% ✓ $570K
Oct 10, 2025 Oct 10, 2025 Gibson Christopher CEO Sell 22.5 -120,000 -11.17% ✓ $604K
Oct 1, 2025 Oct 3, 2025 Li Dean Y Director Neutral 55.0 +1,961 0.06% ✗ -
Oct 1, 2025 Oct 3, 2025 Dar Zavain Director Neutral 77.5 +2,941 2.17% ✗ -
Sep 25, 2025 Sep 26, 2025 Gibson Christopher CEO Sell 26.3 -100,000 -9.49% ✓ $476K
Sep 15, 2025 Sep 17, 2025 Taylor Ben R CFO Sell 48.8 -7,057 -0.87% ✗ $34.1K
Sep 10, 2025 Sep 12, 2025 Gibson Christopher CEO Sell 22.5 -120,000 -11.17% ✓ $471K
Aug 26, 2025 Aug 28, 2025 Gibson Christopher CEO Sell 26.3 -100,000 -9.49% ✓ $484K
Aug 15, 2025 Aug 19, 2025 Taylor Ben R CFO Sell 42.5 -11,908 -1.45% ✗ $67.2K
Aug 15, 2025 Aug 19, 2025 Gibson Christopher CEO Sell 42.5 -40,390 -4.06% ✗ $227.8K
Aug 15, 2025 Aug 19, 2025 Khan Najat Chief R&D Commercial Officer Sell 42.5 -40,388 -5.70% ✗ $223.5K
Aug 11, 2025 Aug 13, 2025 Gibson Christopher CEO Sell 5.0 -628,175 -38.71% ✓ $3.3M
Jul 1, 2025 Jul 3, 2025 Li Dean Y Director Neutral 55.0 +1,949 0.06% ✗ -
Jul 1, 2025 Jul 3, 2025 Dar Zavain Director Neutral 77.5 +2,924 2.20% ✗ -
Jun 18, 2025 Jun 23, 2025 Borgeson Blake Director Neutral 60.0 +22,016 0.31% ✗ -
Jun 18, 2025 Jun 23, 2025 Michor Franziska Director Neutral 90.0 +22,016 20.96% ✗ -
Jun 18, 2025 Jun 23, 2025 HERSHBERG ROBERT Director Neutral 90.0 +22,016 42.57% ✗ -
Jun 18, 2025 Jun 23, 2025 Dar Zavain Director Neutral 90.0 +22,016 19.86% ✗ -
Jun 18, 2025 Jun 23, 2025 Bumpus Namandje Director Neutral 90.0 +11,008 30.12% ✗ -
Jun 18, 2025 Jun 23, 2025 Li Dean Y Director Neutral 67.5 +22,016 0.69% ✗ -
Jun 18, 2025 Jun 23, 2025 Sun Elaine D Director Neutral 90.0 +11,008 30.12% ✗ -
Jun 16, 2025 Jun 18, 2025 Taylor Ben R CFO Sell 48.8 -7,057 -0.85% ✗ $34.7K
May 15, 2025 May 19, 2025 Khan Najat Chief R&D Commercial Officer Sell 48.8 -3,796 -0.53% ✗ $16.1K
May 15, 2025 May 19, 2025 Taylor Ben R CFO Sell 42.5 -11,908 -1.41% ✗ $50.6K
May 15, 2025 May 19, 2025 Gibson Christopher CEO Sell 42.5 -36,197 -3.24% ✗ $153.8K
Apr 1, 2025 Apr 3, 2025 Taylor Ben R CFO Sell 42.5 -26,571 -3.06% ✗ $135.4K
Apr 1, 2025 Apr 3, 2025 Li Dean Y Director Neutral 55.0 +2,268 0.07% ✗ -
Apr 1, 2025 Apr 3, 2025 Dar Zavain Director Neutral 82.5 +2,745 2.54% ✗ -
Mar 27, 2025 Mar 28, 2025 Gibson Christopher CEO Sell 22.5 -138,574 -11.03% ✓ $837K
Mar 17, 2025 Mar 19, 2025 Taylor Ben R CFO Sell 48.8 -7,057 -0.81% ✗ $48.3K
Mar 17, 2025 Mar 19, 2025 Bumpus Namandje Director Neutral 90.0 +36,549 100.00% ✗ -
Mar 17, 2025 Mar 19, 2025 Sun Elaine D Director Neutral 90.0 +36,549 100.00% ✗ -
Mar 19, 2025 Bumpus Namandje Director Neutral 52.5 - 0.00% ✗ -
Mar 19, 2025 Sun Elaine D Director Neutral 52.5 - 0.00% ✗ -
Mar 5, 2025 Mar 7, 2025 Gibson Christopher CEO Sell 42.5 -40,000 -1.57% ✓ $259K
Feb 18, 2025 Feb 20, 2025 Gibson Christopher CEO Sell 42.5 -17,132 -1.35% ✗ $182.3K
Feb 18, 2025 Feb 20, 2025 Taylor Ben R CFO Sell 42.5 -10,879 -1.23% ✗ $115.8K
Feb 5, 2025 Feb 7, 2025 Gibson Christopher CEO Sell 42.5 -40,000 -1.55% ✓ $316K
Feb 3, 2025 Feb 5, 2025 Taylor Ben R CFO Sell 86.3 +42,396 5.02% ✗ $47.4K
Feb 3, 2025 Feb 5, 2025 Khan Najat Chief R&D Commercial Officer Sell 91.3 +215,409 43.34% ✗ $20K
Feb 3, 2025 Feb 5, 2025 Gibson Christopher CEO Sell 91.3 +536,523 72.83% ✗ $40.4K
Jan 8, 2025 Jan 13, 2025 Gibson Christopher CEO Sell 38.8 -40,000 -2.64% ✓ $287.2K
Jan 2, 2025 Jan 6, 2025 Dar Zavain Director Neutral 77.5 +1,907 1.80% ✗ -
Jan 2, 2025 Jan 6, 2025 Li Dean Y Director Neutral 55.0 +1,647 0.05% ✗ -
Jan 2, 2025 Jan 6, 2025 Borgeson Blake Director Neutral 47.5 +1,734 0.02% ✗ -
Dec 19, 2024 Dec 20, 2024 Taylor Ben R CFO Neutral 90.0 +370,343 78.15% ✗ -
Dec 16, 2024 Dec 18, 2024 Taylor Ben R CFO Sell 42.5 -22,725 -4.58% ✗ $143.7K
Dec 4, 2024 Dec 6, 2024 Gibson Christopher CEO Sell 38.8 -40,000 -2.64% ✓ $285.6K
Dec 2, 2024 Taylor Ben R CFO Neutral 52.5 - 0.00% ✗ -
Nov 20, 2024 Nov 22, 2024 Michor Franziska Director Neutral 90.0 +105,037 100.00% ✗ -
Nov 22, 2024 Michor Franziska Director Neutral 52.5 - 0.00% ✗ -
Nov 15, 2024 Nov 19, 2024 Mauro David J Chief Medical Officer Sell 46.3 -4,187 -1.82% ✗ $25.9K
Nov 15, 2024 Nov 19, 2024 Secora Michael CFO Sell 45.0 -11,937 -0.80% ✗ $73.7K
Nov 15, 2024 Nov 19, 2024 Marriott Tina COO Sell 42.5 -14,286 -2.74% ✗ $88.2K
Nov 15, 2024 Nov 19, 2024 Gibson Christopher CEO Sell 42.5 -26,023 -3.41% ✗ $160.7K
Nov 13, 2024 Nov 15, 2024 Gibson Christopher CEO Sell 38.8 -40,000 -2.56% ✓ $301.8K
Nov 12, 2024 Nov 14, 2024 Borgeson Blake Director Sell 50.0 -11,447 -0.16% ✓ $87.5K
Nov 12, 2024 Nov 14, 2024 Secora Michael CFO Sell 47.5 -30,000 -1.00% ✓ $229.5K
Oct 29, 2024 Oct 31, 2024 Borgeson Blake Director Sell 50.0 -11,447 -0.16% ✓ $76.9K
Oct 24, 2024 Oct 28, 2024 Marriott Tina COO Sell 48.8 -6,000 -1.14% ✓ $37.9K
Oct 15, 2024 Oct 17, 2024 Borgeson Blake Director Sell 50.0 -11,447 -0.16% ✓ $76.3K
Oct 8, 2024 Oct 10, 2024 Secora Michael CFO Sell 45.0 -30,000 -1.03% ✓ $190.1K
Oct 1, 2024 Oct 4, 2024 Borgeson Blake Director Neutral 47.5 +2,026 0.03% ✗ -
Oct 1, 2024 Oct 4, 2024 Dar Zavain Director Neutral 77.5 +2,229 2.14% ✗ -
Oct 2, 2024 Oct 4, 2024 Gibson Christopher CEO Sell 41.3 -40,000 -2.56% ✓ $244.8K
Oct 1, 2024 Oct 4, 2024 Li Dean Y Director Neutral 55.0 +1,925 0.06% ✗ -
Oct 1, 2024 Oct 3, 2024 Borgeson Blake Director Sell 50.0 -11,447 -0.16% ✓ $71.2K
Sep 26, 2024 Sep 30, 2024 Marriott Tina COO Sell 48.8 -6,000 -1.14% ✓ $42K
Sep 17, 2024 Sep 19, 2024 Borgeson Blake Director Sell 50.0 -11,447 -0.16% ✓ $78.3K
Sep 10, 2024 Sep 12, 2024 Secora Michael CFO Sell 45.0 -30,000 -1.07% ✓ $187.2K
Sep 4, 2024 Sep 6, 2024 Gibson Christopher CEO Sell 41.3 -40,000 -2.56% ✓ $243.6K
Sep 3, 2024 Sep 5, 2024 Borgeson Blake Director Sell 50.0 -11,447 -0.16% ✓ $71.7K